Dr. David Iberri

Biography

David Iberri is a Clinical Associate Professor in the Department of Medicine at Stanford University, specializing in the treatment of hematologic malignancies, particularly multiple myeloma and Waldenström macroglobulinemia. His clinical focus includes a variety of disorders such as chronic lymphocytic leukemia, acute myeloid leukemia, and polycythemia vera, among others. Dr. Iberri is actively engaged in clinical research aimed at evaluating novel therapeutic agents for hematologic cancers. His research interests are centered on the development and application of biomarkers to identify patients likely to benefit from specific therapies, as well as improving disease monitoring through innovative blood tests to reduce the need for bone marrow biopsies. He completed his fellowship and residency at Stanford University School of Medicine and has received board certifications in Internal Medicine, Medical Oncology, and Hematology. Dr. Iberri is recognized for his contributions to clinical trials that explore various treatment regimens for newly diagnosed multiple myeloma and other related conditions, focusing on improving outcomes for patients.

Research Interests

Experience